Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach.
Journal Articles
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- November 25, 2003
has subject area
- 11 Medical and Health Sciences (FoR)
- Canada (MeSH)
- Drug Evaluation (MeSH)
- Drug Monitoring (MeSH)
- General & Internal Medicine (Science Metrix)
- Humans (MeSH)
- Observation (MeSH)
- Product Surveillance, Postmarketing (MeSH)
- Randomized Controlled Trials as Topic (MeSH)